Precipio (PRPO) Stock Price, News & Analysis

Company Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Key Stats

• Today's Range: $11.23 to $12.45
• 50-Day Range: $5.75 to $12.45
• 52-Week Range: $3.90 to $12.45
• Volume: 40,176 shs
• Average Volume: 9,997 shs
• Market Capitalization: $18.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PRPO Stock Analysis - Frequently Asked Questions

How have PRPO shares performed this year?

Precipio's stock was trading at $5.54 at the start of the year. Since then, PRPO shares have increased by 124.7% and is now trading at $12.45.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) posted its earnings results on Wednesday, May, 14th. The biotechnology company reported ($0.59) earnings per share for the quarter. The biotechnology company earned $4.93 million during the quarter. Precipio had a negative net margin of 15.45% and a negative trailing twelve-month return on equity of 25.87%.
Read the conference call transcript.

When did Precipio's stock split?

Precipio shares reverse split on Friday, September 22nd 2023.The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and GE Aerospace (GE).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 7/04/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:PRPO
• CIK: 1043961
• Web: www.precipiodx.com
• Phone: (203) 787-7888
• Fax: 402-452-5401
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$4.29 million
• Net Margins: -15.45%
• Pretax Margin: -15.45%
• Return on Equity: -25.87%
• Return on Assets: -17.93%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 0.76
• Quick Ratio: 0.57

Sales & Book Value

• Annual Sales: $18.53 million
• Price / Sales: 1.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $8.16 per share
• Price / Book: 1.53

Miscellaneous

• Outstanding Shares: 1,510,000
• Free Float: 1,256,000
• Market Cap: $18.80 million
• Optionable: No Data
• Beta: 1.28